Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Paul Ausick | Mar 27, 2012 at 8:52 AM EDT

Bausch + Lomb Nabs ISTA (ISTA, VRX)

Privately held Bausch + Lomb Inc. has made ISTA Pharmaceuticals Inc. (NASDAQ: ISTA) an offer it can’t refuse. The eye…

Paul Ausick | Mar 26, 2012 at 2:29 PM EDT

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug…

Paul Ausick | Mar 26, 2012 at 11:51 AM EDT

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

An anti-cholesterol drug being co-developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has shown positive results in…

Paul Ausick | Mar 26, 2012 at 10:42 AM EDT

Arena Files for European Drug Review (ARNA, VVUS, OREX)

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has…

Paul Ausick | Mar 26, 2012 at 7:36 AM EDT

AstraZeneca Loses Patent Fight (AZN)

Late last Friday, drug maker AstraZeneca PLC (NYSE: AZN) lost its court fight to prevent a generic version of its…

Paul Ausick | Mar 23, 2012 at 1:48 PM EDT

Standard Register Shares Jump on New Deal (SR)

Printing and communications company Standard Register Co. (NYSE: SR) announced today that it had signed an agreement with HealthTrust Purchasing…

Jon C. Ogg | Mar 23, 2012 at 8:49 AM EDT

Diabetes Drug Approved For Europe (AMLN, LLY)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front. …

Jon C. Ogg | Mar 22, 2012 at 3:59 PM EDT

Durata Therapeutics Files For IPO (DRTX)

A company called Durata Therapeutics, Inc. has filed to come public via an initial public offering. While no terms have been…

Paul Ausick | Mar 21, 2012 at 12:46 PM EDT

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As…

Paul Ausick | Mar 20, 2012 at 12:44 PM EDT

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

Drug developer Targacept Inc. (NASDAQ: TRGT) and partner AstraZeneca plc (NYSE: AZN) today announced that they will not file for…

Jon C. Ogg | Mar 19, 2012 at 4:02 PM EDT

The Generic Boniva Opportunity (RHHBY, MYL)

The Food and Drug Administration approval of the first generic versions of osteoporosis drug Boniva won’t be the end of Roche…

Paul Ausick | Mar 19, 2012 at 11:11 AM EDT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled…

Paul Ausick | Mar 19, 2012 at 10:58 AM EDT

St. Jude, Device Maker Settle Royalty Dispute (STJ, KNSY)

St. Jude Medical Inc. (NYSE: STJ) has settled a royalty dispute with medical device maker Kensey Nash Corp. (NASDAQ: KNSY)…

Paul Ausick | Mar 19, 2012 at 10:45 AM EDT

Ampio Shares Booming on Positive Test Results (AMPE)

Drug maker Ampio Pharmaceuticals Inc. (NASDAQ: AMPE) reported this morning that clinical trials of the company’s Optina treatment for a…

Paul Ausick | Mar 16, 2012 at 3:03 PM EDT

Discovery Labs Shareholders Get Smacked on Secondary Offering (DSCO)

Respiratory drug maker Discovery Laboratories Inc. (NASDAQ: DSCO) priced a secondary offering of slightly more than 16 million shares this…

1 … 321 322 323 324 325 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Bausch + Lomb Nabs ISTA (ISTA, VRX)

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

Arena Files for European Drug Review (ARNA, VVUS, OREX)

AstraZeneca Loses Patent Fight (AZN)

Standard Register Shares Jump on New Deal (SR)

Diabetes Drug Approved For Europe (AMLN, LLY)

Durata Therapeutics Files For IPO (DRTX)

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

The Generic Boniva Opportunity (RHHBY, MYL)

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

St. Jude, Device Maker Settle Royalty Dispute (STJ, KNSY)

Ampio Shares Booming on Positive Test Results (AMPE)

Discovery Labs Shareholders Get Smacked on Secondary Offering (DSCO)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Bausch + Lomb Nabs ISTA (ISTA, VRX)

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

Arena Files for European Drug Review (ARNA, VVUS, OREX)

AstraZeneca Loses Patent Fight (AZN)

Standard Register Shares Jump on New Deal (SR)

Diabetes Drug Approved For Europe (AMLN, LLY)

Durata Therapeutics Files For IPO (DRTX)

Dendreon Rises on Takeover Chatter (DNDN, LLY, AMGN)

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

The Generic Boniva Opportunity (RHHBY, MYL)

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

St. Jude, Device Maker Settle Royalty Dispute (STJ, KNSY)

Ampio Shares Booming on Positive Test Results (AMPE)

Discovery Labs Shareholders Get Smacked on Secondary Offering (DSCO)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500